We are live on
!
Find out more
SCM
Scopia Capital Management Portfolio holdings
AUM
$112M
1-Year Est. Return
48.41%
This Fund
S&P 500
This Quarter
Est. Return
+6.25%
1 Year Est. Return
+48.41%
3 Year Est. Return
+58.7%
5 Year Est. Return
+80.15%
10 Year Est. Return
+533.22%
AUM
$5.2B
AUM Growth
-$526M
(-9.2%)
Cap. Flow
-$267M
Cap. Flow
% of AUM
-5.14%
Top 10 Holdings %
Top 10 Hldgs %
61.55%
Holding
40
New
2
Increased
12
Reduced
16
Closed
2
Avg Time Held Equity + Options
5
quarters
Top 10 Avg Time Held Equity + Options
6
quarters
Top 20 Avg Time Held Equity + Options
6.8
quarters
Avg Time Held Equity only
5.1
quarters
Top 10 Avg Time Held Equity only
7.4
quarters
Top 20 Avg Time Held Equity only
6.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$125M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$91.6M |
| 3 |
Vistra
VST
|
+$84.5M |
| 4 |
JD.com
JD
|
+$68.6M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$54.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Optimum Communications Inc
OPTU
|
+$172M |
| 2 |
Wayfair
W
|
+$156M |
| 3 |
Baidu
BIDU
|
+$123M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$83M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$79.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32% |
| 2 | Industrials | 15.06% |
| 3 | Real Estate | 13.9% |
| 4 | Technology | 11.45% |
| 5 | Miscellaneous | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FCE.A
1
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $544M | 10.47% |
21,672,157
-415,646
| -2% | -$10.1M |
2013 Q2
21 quarters
|
|
2
DELISTED
Spirit AeroSystems
SPR
| $491M | 9.46% |
5,361,113
+310,584
| +6% | +$27.3M |
2013 Q2
21 quarters
|
|
3
Itron
ITRI
$3.74B
| $347M | 6.67% |
5,400,168
-84,721
| -2% | -$5.34M |
2015 Q3
12 quarters
|
|
|
4
Vistra
VST
$53.7B
| $300M | 5.78% |
12,071,361
+3,672,849
| +44% | +$84.5M |
2017 Q2
5 quarters
|
|
|
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $289M | 5.56% |
14,762,354
+2,850,064
| +24% | +$54.2M |
2016 Q4
7 quarters
|
|
|
ZGNX
6
DELISTED
Zogenix, Inc.
ZGNX
| $263M | 5.07% |
5,306,514
+1,798,786
| +51% | +$91.6M |
2017 Q4
3 quarters
|
|
7
Johnson Controls International
JCI
$94.9B
| $262M | 5.04% |
7,478,853
-17,775
| -0.2% | -$655K |
2016 Q2
9 quarters
|
|
|
GWPH
8
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $257M | 4.94% |
1,487,307
-550,818
| -27% | -$79.4M |
2016 Q2
9 quarters
|
|
|
ARRS
9
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $234M | 4.5% |
9,000,000
+4,892,434
| +119% | +$125M |
2018 Q1
2 quarters
|
|
10
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $211M | 4.06% |
726,100
-666,000
| -48% | -$190M |
2017 Q3
4 quarters
|
|
11
Travere Therapeutics
TVTX
$4.97B
| $187M | 3.6% |
6,519,425
| – | – |
2015 Q4
11 quarters
|
|
|
12
JD.com
JD
$36.3B
| $186M | 3.59% |
7,143,928
+2,094,656
| +41% | +$68.6M |
2016 Q1
10 quarters
|
|
|
ISBC
13
DELISTED
Investors Bancorp, Inc.
ISBC
| $174M | 3.35% |
14,190,051
+3,168,837
| +29% | +$40.3M |
2017 Q3
4 quarters
|
|
|
SRC
14
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $151M | 2.9% |
3,738,717
-1,122,370
| -23% | -$46.5M |
2017 Q2
5 quarters
|
|
|
ACOR
15
DELISTED
Acorda Therapeutics
ACOR
| $140M | 2.69% |
59,225
-4,413
| -7% | -$13.7M |
2015 Q3
12 quarters
|
|
|
MNK
16
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $138M | 2.67% |
4,724,581
-2,947,631
| -38% | -$83M |
2017 Q4
3 quarters
|
|
|
17
Wayfair
W
$14.7B
| $132M | 2.54% |
892,600
-1,229,595
| -58% | -$156M |
2018 Q2
1 quarter
|
|
18
EQT Corp
EQT
$33.3B
| $105M | 2.02% |
4,360,360
+938,977
| +27% | +$25.9M |
2018 Q2
1 quarter
|
|
19
CONMED
CNMD
$1.34B
| $95.4M | 1.84% |
1,204,851
-519,194
| -30% | -$40.2M |
2016 Q1
10 quarters
|
|
20
PUT
iShares Russell 2000 ETF
IWM
$78.5B
| $85.3M | 1.64% |
506,200
-2,090,500
| -81% | -$353M |
2017 Q4
3 quarters
|
|
|
WFT
21
DELISTED
Weatherford International plc
WFT
| $84.1M | 1.62% |
31,019,881
+4,340,119
| +16% | +$12.7M |
2017 Q3
4 quarters
|
|
22
PTC Therapeutics
PTCT
$5.33B
| $76M | 1.46% |
1,616,998
-686,343
| -30% | -$28.4M |
2017 Q3
4 quarters
|
|
|
AUD
23
DELISTED
Audacy, Inc.
AUD
| $62.8M | 1.21% |
7,950,651
-2,373,950
| -23% | -$18.4M |
2017 Q2
5 quarters
|
|
24
Tenet Healthcare
THC
$21.6B
| $52.8M | 1.02% |
1,856,285
+48
| +0% | +$1.58K |
2018 Q1
2 quarters
|
|
|
LJPC
25
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $52.1M | 1% |
2,590,212
+7,042
| +0.3% | +$184K |
2018 Q1
2 quarters
|
|
Similar funds
TFS
WAM
CS
BU
TBFA
VDC
RQS
IMT
Scopia Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Scopia Capital Management held 40 positions worth $5.2B, down 9.2% from $5.72B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Scopia Capital Management withdrew a net $267M in Q3 2018, closing 2 positions and reducing 16 holdings. Its most notable exit was Optimum Communications Inc, an estimated $172M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Industrials and Real Estate.
Against the trend, Scopia Capital Management opened a new position in Y-mAbs Therapeutics worth $42.2M.
- Scopia Capital Management's largest Q3 2018 buy was Y-mAbs Therapeutics: 1,587,566 shares worth $42.2M.
- Scopia Capital Management added most to ARRIS International plc Ordinary Shares in Q3 2018, an estimated $125M increase.
- Scopia Capital Management's biggest Q3 2018 reduction was Wayfair, cutting an estimated $156M.
- Scopia Capital Management fully exited Optimum Communications Inc in Q3 2018, selling an estimated $172M.
- Scopia Capital Management's ten largest holdings make up 62% of its $5.2B portfolio in Q3 2018.
- Scopia Capital Management opened 2 new positions and closed 2 in Q3 2018.
- Scopia Capital Management's portfolio value fell 9.2% quarter-over-quarter to $5.2B.
Based on Scopia Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.